Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 44931 | 28.11 |
09:34 ET | 4918 | 28.09 |
09:36 ET | 3918 | 27.99 |
09:38 ET | 1200 | 27.965 |
09:39 ET | 400 | 27.96 |
09:41 ET | 700 | 27.94 |
09:43 ET | 900 | 27.93 |
09:45 ET | 1313 | 27.92 |
09:48 ET | 6182 | 27.91 |
09:50 ET | 9747 | 27.89 |
09:52 ET | 5012 | 27.865 |
09:54 ET | 5108 | 27.89 |
09:56 ET | 11380 | 27.85 |
09:57 ET | 5664 | 27.8 |
09:59 ET | 5068 | 27.85 |
10:01 ET | 3654 | 27.84 |
10:03 ET | 3112 | 27.815 |
10:06 ET | 11265 | 27.855 |
10:08 ET | 12714 | 27.9 |
10:10 ET | 9775 | 27.98 |
10:12 ET | 5307 | 27.95 |
10:14 ET | 2961 | 27.97 |
10:15 ET | 3393 | 27.98 |
10:17 ET | 748 | 27.965 |
10:19 ET | 2764 | 27.995 |
10:21 ET | 3826 | 27.97 |
10:24 ET | 2154 | 27.935 |
10:26 ET | 2188 | 27.94 |
10:28 ET | 200 | 27.945 |
10:30 ET | 1200 | 27.945 |
10:32 ET | 1568 | 27.93 |
10:33 ET | 1038 | 27.9464 |
10:35 ET | 1099 | 27.955 |
10:37 ET | 2203 | 27.965 |
10:39 ET | 1784 | 27.955 |
10:42 ET | 1849 | 27.93 |
10:44 ET | 1226 | 27.915 |
10:46 ET | 2660 | 27.925 |
10:48 ET | 1304 | 27.925 |
10:50 ET | 1550 | 27.935 |
10:51 ET | 1910 | 27.925 |
10:53 ET | 3854 | 27.925 |
10:55 ET | 2676 | 27.94 |
10:57 ET | 2374 | 27.945 |
11:00 ET | 4102 | 27.94 |
11:02 ET | 2035 | 27.9 |
11:04 ET | 2290 | 27.89 |
11:06 ET | 1756 | 27.88 |
11:08 ET | 2054 | 27.9 |
11:09 ET | 896 | 27.91 |
11:11 ET | 1596 | 27.905 |
11:13 ET | 809 | 27.9 |
11:15 ET | 2189 | 27.915 |
11:18 ET | 1526 | 27.95 |
11:20 ET | 1742 | 27.95 |
11:22 ET | 441 | 27.95 |
11:24 ET | 2540 | 27.94 |
11:26 ET | 1907 | 27.95 |
11:27 ET | 500 | 27.94 |
11:29 ET | 500 | 27.93 |
11:31 ET | 841 | 27.955 |
11:33 ET | 1809 | 27.945 |
11:36 ET | 1796 | 27.95 |
11:38 ET | 2011 | 27.965 |
11:40 ET | 3124 | 27.965 |
11:42 ET | 1077 | 27.96 |
11:44 ET | 1882 | 27.965 |
11:45 ET | 1989 | 27.97 |
11:47 ET | 500 | 27.975 |
11:49 ET | 3379 | 27.99 |
11:51 ET | 670 | 27.98 |
11:54 ET | 1327 | 27.98 |
11:56 ET | 4640 | 27.955 |
11:58 ET | 2121 | 27.94 |
12:00 ET | 1471 | 27.95 |
12:02 ET | 1544 | 27.935 |
12:03 ET | 800 | 27.915 |
12:05 ET | 1025 | 27.925 |
12:07 ET | 3569 | 27.925 |
12:09 ET | 1600 | 27.915 |
12:12 ET | 12853 | 27.915 |
12:14 ET | 3066 | 27.92 |
12:16 ET | 2580 | 27.915 |
12:18 ET | 1300 | 27.915 |
12:20 ET | 1340 | 27.925 |
12:21 ET | 1121 | 27.924 |
12:23 ET | 4196 | 27.925 |
12:25 ET | 3904 | 27.955 |
12:27 ET | 2500 | 27.955 |
12:30 ET | 6409 | 27.955 |
12:32 ET | 1000 | 27.94 |
12:34 ET | 523 | 27.945 |
12:36 ET | 1900 | 27.935 |
12:38 ET | 3424 | 27.925 |
12:39 ET | 3014 | 27.945 |
12:41 ET | 2998 | 27.94 |
12:43 ET | 2962 | 27.925 |
12:45 ET | 1830 | 27.925 |
12:48 ET | 2070 | 27.915 |
12:50 ET | 2253 | 27.915 |
12:52 ET | 2218 | 27.9 |
12:54 ET | 3422 | 27.9 |
12:56 ET | 1699 | 27.905 |
12:57 ET | 1713 | 27.92 |
12:59 ET | 1897 | 27.92 |
01:01 ET | 1913 | 27.915 |
01:03 ET | 1866 | 27.92 |
01:06 ET | 465 | 27.91 |
01:08 ET | 5088 | 27.885 |
01:10 ET | 2265 | 27.885 |
01:12 ET | 4258 | 27.865 |
01:14 ET | 3227 | 27.875 |
01:15 ET | 3309 | 27.865 |
01:17 ET | 4774 | 27.855 |
01:19 ET | 14732 | 27.81 |
01:21 ET | 400 | 27.815 |
01:24 ET | 800 | 27.815 |
01:26 ET | 5822 | 27.83 |
01:28 ET | 1561 | 27.84 |
01:30 ET | 1917 | 27.8 |
01:32 ET | 600 | 27.795 |
01:33 ET | 2607 | 27.805 |
01:35 ET | 2136 | 27.81 |
01:37 ET | 1429 | 27.815 |
01:39 ET | 3396 | 27.815 |
01:42 ET | 4459 | 27.81 |
01:44 ET | 1521 | 27.81 |
01:46 ET | 1724 | 27.815 |
01:48 ET | 1933 | 27.83 |
01:50 ET | 1811 | 27.821 |
01:51 ET | 1356 | 27.82 |
01:53 ET | 1946 | 27.835 |
01:55 ET | 947 | 27.831 |
01:57 ET | 595 | 27.83 |
02:00 ET | 2626 | 27.83 |
02:02 ET | 217 | 27.83 |
02:04 ET | 906 | 27.835 |
02:06 ET | 1688 | 27.825 |
02:08 ET | 700 | 27.825 |
02:09 ET | 3526 | 27.81 |
02:11 ET | 771 | 27.82 |
02:13 ET | 1863 | 27.835 |
02:15 ET | 2513 | 27.815 |
02:18 ET | 735 | 27.82 |
02:20 ET | 1562 | 27.795 |
02:22 ET | 3674 | 27.79 |
02:24 ET | 7323 | 27.8 |
02:26 ET | 1527 | 27.805 |
02:27 ET | 2127 | 27.805 |
02:29 ET | 3122 | 27.8066 |
02:31 ET | 4295 | 27.79 |
02:33 ET | 1341 | 27.8 |
02:36 ET | 1296 | 27.795 |
02:38 ET | 2929 | 27.775 |
02:40 ET | 1386 | 27.7725 |
02:42 ET | 2713 | 27.785 |
02:44 ET | 1700 | 27.7855 |
02:45 ET | 4851 | 27.775 |
02:47 ET | 1367 | 27.775 |
02:49 ET | 500 | 27.775 |
02:51 ET | 6318 | 27.765 |
02:54 ET | 7659 | 27.765 |
02:56 ET | 1173 | 27.755 |
02:58 ET | 1829 | 27.75 |
03:00 ET | 1469 | 27.73 |
03:02 ET | 1963 | 27.71 |
03:03 ET | 13085 | 27.72 |
03:05 ET | 1289 | 27.71 |
03:07 ET | 4181 | 27.72 |
03:09 ET | 300 | 27.715 |
03:12 ET | 6311 | 27.71 |
03:14 ET | 3000 | 27.715 |
03:16 ET | 1327 | 27.725 |
03:18 ET | 1800 | 27.711 |
03:20 ET | 7505 | 27.735 |
03:21 ET | 1186 | 27.73 |
03:23 ET | 2989 | 27.73 |
03:25 ET | 2700 | 27.735 |
03:27 ET | 2237 | 27.75 |
03:30 ET | 8135 | 27.71 |
03:32 ET | 45350 | 27.745 |
03:34 ET | 1000 | 27.735 |
03:36 ET | 3274 | 27.73 |
03:38 ET | 6041 | 27.71 |
03:39 ET | 1321 | 27.705 |
03:41 ET | 6694 | 27.705 |
03:43 ET | 2942 | 27.705 |
03:45 ET | 6296 | 27.715 |
03:48 ET | 11201 | 27.735 |
03:50 ET | 8374 | 27.715 |
03:52 ET | 13731 | 27.745 |
03:54 ET | 8751 | 27.745 |
03:56 ET | 16031 | 27.745 |
03:57 ET | 21183 | 27.725 |
03:59 ET | 360136 | 27.75 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.8B | 18.4x | +1.83% |
Amneal Pharmaceuticals Inc | 2.7B | -13.7x | --- |
Endo Inc | 1.9B | 0.4x | --- |
Catalent Inc | 11.0B | -10.6x | --- |
Jazz Pharmaceuticals PLC | 6.8B | 18.6x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 593.5M |
Dividend Yield | 3.03% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.4x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 20.0x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.